HomeFAE • BME
add
FAES Farma SA
Previous close
€4.76
Day range
€4.75 - €4.81
Year range
€3.27 - €4.81
Market cap
1.51B EUR
Avg Volume
119.23K
P/E ratio
14.25
Dividend yield
3.74%
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 146.61M | 22.94% |
Operating expense | 68.06M | 26.19% |
Net income | 21.23M | -1.21% |
Net profit margin | 14.48 | -19.64% |
Earnings per share | — | — |
EBITDA | 30.15M | 0.93% |
Effective tax rate | 14.91% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 111.62M | 59.82% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 730.04M | — |
Shares outstanding | 311.26M | — |
Price to book | 2.04 | — |
Return on assets | — | — |
Return on capital | 8.03% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 21.23M | -1.21% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Faes Farma, originally Fábrica Española de Productos Químicos y Farmacéuticos, is a Spanish pharmaceutical company based in the Lamiaco district of Lejona in Biscay. Founded on 29 July 1933 by the Serra family with an initial capital of two million pesetas, it pioneered the development of various therapeutic compounds and has been listed on the Madrid Stock Exchange since the 1940s.
Faes Farma’s headquarters, production facilities, and R&D center are located in Lejona, with additional offices in Madrid and Barcelona. The group also operates subsidiaries in Portugal, Italy, Mexico, Guatemala, Colombia, Chile, Peru, Bolivia, Ecuador and Nigeria, and maintains an animal nutrition and health division under the name FARM Faes. Wikipedia
Founded
Jul 29, 1933
Website
Employees
1,894
